| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 18, 2018 | 64.71 | 72.00 | 64.71 | 69.10 | 112,515 |
| Oct 17, 2018 | 66.79 | 69.80 | 63.10 | 65.10 | 270,626 |
| Oct 16, 2018 | 72.80 | 73.60 | 63.75 | 65.50 | 529,636 |
| Oct 15, 2018 | 75.89 | 77.10 | 74.00 | 77.00 | 10,002 |
| Oct 12, 2018 | 75.50 | 77.30 | 73.70 | 75.90 | 98,455 |
| Name | Circassia Pharmaceuticals | Epic | CIR |
|---|---|---|---|
| ISIN | GB00BJVD3B28 | Currency | GBX |
| Type | Equity | Trading Segment | SSMM |
| Record Status | Active | Trading Status | Closed |
| Industry | Health Care | Sector | Pharmaceuticals & Biotechnology |
| EMS | 5,000 | Prev Close | 65.15 |
| Shares in Issue (m) | 357.23 | Market Cap (£m) | 232.56 |
| PE Ratio | -2.10 | Div per Share (p) | 0.00 |
| Div Yield | 0.00 | Div Cover | 0.00 |
| EPS | -31.00 | EPS Growth (%) | 35.42 |
| PEG | -0.06 | DPS Growth (%) | n/a |
| ROCE | -30.57 | Net Gearing | 33.08 |
| Quick Ratio | 2.76 | Current Ratio | 2.92 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 17 Oct | RBC Capital Markets | Sector Performer | 65.15 | 86.00 | 81.00 | Reiterates |
| 03 Oct | Peel Hunt | Buy | 65.15 | 120.00 | - | Reiterates |
| 27 Sep | Numis | Buy | 65.15 | 140.00 | - | Reiterates |
| 27 Sep | Peel Hunt | Buy | 65.15 | 120.00 | - | Upgrades |
| 04 Sep | Peel Hunt | Hold | 65.15 | 120.00 | - | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 17 Jul 2017 | Steven Harris | Exercise | 535,375 @ 0.08p | £428.30 |
| 18 Sep 2015 | Charles Swingland | Sell | 1,230,000 @ 318.24p | £3,914,352.00 |
| 18 Sep 2015 | Charles Swingland | Sell | 9,000 @ 318.72p | £28,684.80 |
| 18 Sep 2015 | Charles Swingland | Sell | 754,548 @ 320.24p | £2,416,364.52 |
| 27 Mar 2014 | Dr Rod Hafner | Exercise | 212,375 @ 0.08p | £169.90 |
